Literature DB >> 33384429

Venous thromboembolism in patients hospitalized for knee joint replacement surgery.

Karsten Keller1,2, Lukas Hobohm3,4, Stefano Barco4,5, Irene Schmidtmann6, Thomas Münzel3,7, Martin Engelhardt8,9, Lukas Eckhard10, Stavros V Konstantinides4,11, Philipp Drees10.   

Abstract

Patients undergoing knee joint replacement (KJR) are at high risk of postoperative venous thromboembolism (VTE), but data on the time trends of VTE rate in this population are sparse. In this analysis of the German nationwide inpatient sample, we included all hospitalizations for elective primary KJR in Germany 2005-2016. Overall, 1,804,496 hospitalized patients with elective primary KJR (65.1% women, 70.0 years [IQR 63.0-76.0]) were included in the analysis. During hospitalization, VTE was documented in 23,297 (1.3%) patients. Total numbers of primary KJR increased from 129,832 in 2005 to 167,881 in 2016 (β-(slope)-estimate 1,978 [95% CI 1,951 to 2,004], P < 0.001). In-hospital VTE decreased from 2,429 (1.9% of all hospitalizations for KJR) to 1,548 (0.9%) cases (β-estimate - 0.77 [95% CI - 0.81 to - 0.72], P < 0.001), and in-hospital death rate from 0.14% (184 deaths) to 0.09% (146 deaths) (β-estimate - 0.44 deaths per year [95% CI - 0.59 to - 0.30], P < 0.001). Infections during hospitalization were associated with a higher VTE risk. VTE events were independently associated with in-hospital death (OR 20.86 [95% CI 18.78-23.15], P < 0.001). Annual number of KJR performed in Germany increased by almost 30% between 2005 and 2016. In parallel, in-hospital VTE rates decreased from 1.9 to 0.9%. Perioperative infections were associated with higher risk for VTE. Patients who developed VTE had a 21-fold increased risk of in-hospital death.

Entities:  

Mesh:

Year:  2020        PMID: 33384429      PMCID: PMC7775461          DOI: 10.1038/s41598-020-79490-w

Source DB:  PubMed          Journal:  Sci Rep        ISSN: 2045-2322            Impact factor:   4.379


  52 in total

1.  Incidence of deep vein thrombosis following total hip arthroplasty: a Doppler ultrasonographic study.

Authors:  Keng Lin Wong; Richillo Daguman; Kay Hui Lim; Liang Shen; Krishna Lingaraj
Journal:  J Orthop Surg (Hong Kong)       Date:  2011-04       Impact factor: 1.118

2.  Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  Yngve Falck-Ytter; Charles W Francis; Norman A Johanson; Catherine Curley; Ola E Dahl; Sam Schulman; Thomas L Ortel; Stephen G Pauker; Clifford W Colwell
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

3.  Prevention of venous thromboembolism in total knee and hip replacement.

Authors:  David Warwick
Journal:  Circulation       Date:  2012-05-01       Impact factor: 29.690

Review 4.  Venous thromboembolism and atherosclerosis: common denominators or different diseases?

Authors:  G Agnelli; C Becattini
Journal:  J Thromb Haemost       Date:  2006-09       Impact factor: 5.824

5.  Trends in mortality related to pulmonary embolism in the European Region, 2000-15: analysis of vital registration data from the WHO Mortality Database.

Authors:  Stefano Barco; Seyed Hamidreza Mahmoudpour; Luca Valerio; Frederikus A Klok; Thomas Münzel; Saskia Middeldorp; Walter Ageno; Alexander T Cohen; Beverley J Hunt; Stavros V Konstantinides
Journal:  Lancet Respir Med       Date:  2019-10-12       Impact factor: 30.700

6.  Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis.

Authors:  Henrik T Sørensen; Erzsebet Horvath-Puho; Timothy L Lash; Christian F Christiansen; Raffaele Pesavento; Lars Pedersen; John A Baron; Paolo Prandoni
Journal:  Circulation       Date:  2011-09-06       Impact factor: 29.690

7.  Venous thromboembolism in patients hospitalized for hip joint replacement surgery.

Authors:  Karsten Keller; Lukas Hobohm; Stefano Barco; Irene Schmidtmann; Thomas Münzel; Martin Engelhardt; Markus Goldhofer; Stavros V Konstantinides; Philipp Drees
Journal:  Thromb Res       Date:  2020-03-27       Impact factor: 3.944

8.  Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study.

Authors:  L B Rinde; C Lind; B Småbrekke; I Njølstad; E B Mathiesen; T Wilsgaard; M-L Løchen; E M Hald; A Vik; S K Braekkan; J-B Hansen
Journal:  J Thromb Haemost       Date:  2016-05-10       Impact factor: 5.824

9.  Reduced short-term complications and mortality following Enhanced Recovery primary hip and knee arthroplasty: results from 6,000 consecutive procedures.

Authors:  Sameer K Khan; Ajay Malviya; Scott D Muller; Ian Carluke; Paul F Partington; Kevin P Emmerson; Mike R Reed
Journal:  Acta Orthop       Date:  2013-12-20       Impact factor: 3.717

10.  CRISTAL: protocol for a cluster randomised, crossover, non-inferiority trial of aspirin compared to low molecular weight heparin for venous thromboembolism prophylaxis in hip or knee arthroplasty, a registry nested study.

Authors:  Verinder Singh Sidhu; Steven E Graves; Rachelle Buchbinder; Justine Maree Naylor; Nicole L Pratt; Richard S de Steiger; Beng H Chong; Ilana N Ackerman; Sam Adie; Anthony Harris; Amber Hansen; Maggie Cripps; Michelle Lorimer; Steve Webb; Ornella Clavisi; Elizabeth C Griffith; Durga Anandan; Grace O'Donohue; Thu-Lan Kelly; Ian A Harris
Journal:  BMJ Open       Date:  2019-11-06       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.